☆ 4.7 Article

Anti-cancer effect of COVID-19 vaccines in mice models

LIFE SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy

Mona Ariamanesh et al.

Summary: The study confirmed the safety and short-term efficacy of the inactivated SARS-CoV-2 vaccine in cancer patients, with an overall seroconversion rate of 86.9%. However, the conversion rate was lower in older age groups, those with hematological malignancies, and recipients of chemotherapy.

CANCER INVESTIGATION (2022)

添加到收藏夹

Review Oncology

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

Annika Fendler et al.

Summary: The efficacy and immunogenicity of COVID-19 vaccines in cancer patients are uncertain due to their exclusion from pivotal clinical trials. In this Review, the current knowledge on vaccine efficacy and immune responses in cancer patients is summarized, highlighting key factors that may affect vaccine efficacy in this population.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Long-term adverse events of three COVID-19 vaccines as reported by vaccinated physicians and dentists, a study from Jordan and Saudi Arabia

Najla Dar-Odeh et al.

Summary: This study explored long-term adverse events reported by physicians and dentists who received at least two COVID-19 vaccine doses. The results showed that less than 20% of recipients experienced fatigue-related long-term adverse events, and factors such as age, gender, and medical history had negligible impact on the occurrence of these events. The Sinopharm vaccine showed the highest significant association with these events.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2022)

添加到收藏夹

Article Immunology

COVID-19 Vaccination Status and Hesitancy among Breast Cancer Patients after Two Years of Pandemic: A Cross-Sectional Survey

Weijing Liu et al.

Summary: The study conducted in China on breast cancer patients revealed that 55.2% had received a COVID-19 vaccine, with around 40% experiencing adverse events per dose. Vaccine hesitancy of 61.9% was observed among patients who had not fully received three doses of vaccine or boosters. Time since diagnosis was found to be the only variable associated with vaccine hesitancy.

VACCINES (2022)

添加到收藏夹

Review Oncology

COVID-19 Vaccination in Cancer Patients: A Review Article

Rana Mekkawi et al.

Summary: COVID-19 vaccination is recommended for cancer patients, but there are important issues that need to be addressed, including the safety and efficacy evaluation of the vaccines and the lack of observational studies on cancer patients.

CANCER CONTROL (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms

Rong En Tay et al.

Summary: Cancer immunotherapy has transformed cancer treatment, with immune checkpoint blockade therapy and adoptive cell therapy becoming standard care for many cancer types. Recent evidence suggests that CD4(+)T cells play a significant role in the anti-tumour immune response, highlighting their potential importance in cancer immunotherapies.

CANCER GENE THERAPY (2021)

添加到收藏夹

Review Oncology

Cytotoxic CD8+T cells in cancer and cancer immunotherapy

Hans Raskov et al.

Summary: The functions and interactions between the innate and adaptive immune systems play a crucial role in anticancer immunity. Cytotoxic T cells with CD8 as the most effective effectors in the anticancer immune response form the basis of successful cancer immunotherapies. Advancements in genetically modified or synthetic receptors on cytotoxic T cells are being developed for future cancer treatment. Combinatory regimens may optimize treatment effects and reduce adverse events in cancer therapy.

BRITISH JOURNAL OF CANCER (2021)

添加到收藏夹

Editorial Material Oncology

COVID-19 vaccine race: watch your step for cancer patients

Raphaelle Fanciullino et al.

Summary: Although cancer patients may benefit from COVID-19 vaccination using mRNA encapsulated into lipid carriers, the extent to which solid tumors can uptake the vaccine dose is still unknown, calling for a careful evaluation for optimal protection of this specific and frail population.

BRITISH JOURNAL OF CANCER (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients

Jeyasakthy Saniasiaya et al.

Summary: A systematic review and meta-analysis found that the overall prevalence of olfactory dysfunction in COVID-19 patients is 47.85%, with European patients having the highest prevalence and Asian patients the lowest. Discrepancies between objective and subjective evaluations suggest further studies are needed.

LARYNGOSCOPE (2021)

添加到收藏夹

Review Otorhinolaryngology

Prevalence and Characteristics of Taste Disorders in Cases of COVID-19: A Meta-analysis of 29,349 Patients

Jeyasakthy Saniasiaya et al.

Summary: The aim of this study was to evaluate the prevalence of taste disorders and their subtypes in patients with COVID-19, with a pooled prevalence of taste disorders found to be 48.1%. It was observed that studies with objective assessments had higher prevalence rates compared to subjective assessments. Dysgeusia was the most common subtype, followed by ageusia and hypogeusia.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2021)

添加到收藏夹

Article Oncology

SARS-CoV-2 vaccines for cancer patients: a call to action

Chiara Corti et al.

Summary: The COVID-19 pandemic has affected over 96 million people globally, with cancer patients at a higher risk of severe illness. Efforts to develop effective vaccines are crucial, but cancer patients may be underrepresented in clinical trials. Real-time data on vaccine recipients, including cancer patients, is needed to ensure safety and efficacy. Prioritizing vaccinations for cancer patients and implementing pharmacovigilance registries are important steps in attenuating the consequences of the pandemic for this vulnerable population.

EUROPEAN JOURNAL OF CANCER (2021)

添加到收藏夹

Review Immunology

COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects

Shen Wang et al.

Summary: The global COVID-19 pandemic has posed an unprecedented challenge to public health, prompting the urgent need for reliable animal models to evaluate vaccines and therapeutic drugs. Currently, a variety of animal models are being utilized in COVID-19 research, with 117 vaccine candidates progressing to clinical trials. These vaccine candidates, ranging from inactivated vaccines to mRNA vaccines, show promising efficacy rates ranging from about 50% to over 95%.

VACCINES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients

Md Asiful Islam et al.

Summary: The study showed that the prevalence of fever in adult COVID-19 patients was as high as 79.43%, but 54.14% of pediatric patients did not exhibit fever initially. The prevalence and risk of low and medium-grade fevers were higher compared to high-grade fever.

PLOS ONE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Necroptosis triggered by ROS accumulation and Ca2+ overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo

Mojdeh Barati et al.

Summary: The study reported the anti-cancer effects of extremely low frequency magnetic fields (ELF-EMF) on breast cancer cells, inducing necroptosis in vitro and in vivo. Elevated levels of pro-inflammatory cytokines, lymphocyte infiltration, and suppression of tumor growth were observed, along with increased phosphorylation of RIPK1/RIPK3/MLKL proteins and cleavage of caspase-9/caspase-3, implicating both necroptosis and apoptosis in cell death induced by ELF-EMF.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

添加到收藏夹

Article Oncology

COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience

Alfred Chung Pui So et al.

Summary: This study investigated the safety of COVID-19 vaccines in cancer patients at a center in London, finding that these patients generally tolerated the vaccines well with mild reactogenicity, experiencing common side effects such as sore arm, fatigue, and headaches. The results suggest that COVID-19 vaccines could be a feasible option for oncology patients, allowing for a return to pre-pandemic oncology care.

CANCERS (2021)

添加到收藏夹

Review Immunology

Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action

Franz X. Heinz et al.

Summary: COVID-19 vaccines have been rapidly developed using different technologies, including mRNA, adenoviral vectors, and inactivated vaccines. They all rely on the viral spike protein of SARS-CoV-2 to induce neutralizing antibodies, but the presentation of this key antigen to the immune system varies between different vaccine categories.

NPJ VACCINES (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Coronavirus Infections-More Than Just the Common Cold

Catharine I. Paules et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Jasper Fuk-Woo Chan et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Infectious Diseases

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

Heshui Shi et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Editorial Material Medicine, General & Internal

The Development of COVID-19 Vaccines Safeguards Needed

Nicole Lurie et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Infectious Diseases

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

Haiyan Qiu et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Review Clinical Neurology

Prevalence of Headache in Patients With Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of 14,275 Patients

Md Asiful Islam et al.

FRONTIERS IN NEUROLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Ki-67: more than a proliferation marker

Xiaoming Sun et al.

CHROMOSOMA (2018)

添加到收藏夹

Article Immunology

Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-kappa B p65 signaling pathway

Jing Tian et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

CD4 and CD8 T lymphocyte interplay in controlling tumor growth

Dmitrij Ostroumov et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

添加到收藏夹

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

PET Assessment of Vascular Inflammation and Atherosclerotic Plaques: SUV or TBR?

Wengen Chen et al.

JOURNAL OF NUCLEAR MEDICINE (2015)

添加到收藏夹

Review Oncology

VEGF targets the tumour cell

Hira Lal Goel et al.

NATURE REVIEWS CANCER (2013)

添加到收藏夹

Article Oncology

A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease

Punit Kau et al.

BMC CANCER (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

Chrisostomi Gialeli et al.

FEBS JOURNAL (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.